| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 29, 2024 | Sale | $1.58 | 8,661 | 13,684 | 706,932 | Mar 01, 2024, 05:49 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Feb 29, 2024 | Sale | $1.58 | 5,974 | 9,439 | 663,259 | Mar 01, 2024, 05:48 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Feb 29, 2024 | Sale | $1.58 | 46,570 | 73,581 | 2,044,580 | Mar 01, 2024, 05:47 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Feb 29, 2024 | Sale | $1.58 | 7,169 | 11,327 | 695,840 | Mar 01, 2024, 05:46 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Feb 27, 2024 | Sale | $1.52 | 7,411 | 11,265 | 669,233 | Feb 29, 2024, 06:03 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 27, 2024 | Sale | $1.52 | 10,744 | 16,331 | 715,593 | Feb 29, 2024, 06:02 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Feb 27, 2024 | Sale | $1.52 | 8,367 | 12,718 | 703,009 | Feb 29, 2024, 06:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Feb 27, 2024 | Sale | $1.52 | 37,733 | 57,354 | 2,091,150 | Feb 29, 2024, 06:00 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Feb 01, 2024 | Sale | $1.68 | 24,311 | 40,842 | 711,376 | Feb 02, 2024, 04:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | May 25, 2023 | Sale | $1.22 | 63,186 | 77,270 | 524,344 | May 25, 2023, 09:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | May 25, 2023 | Sale | $1.22 | 95,478 | 116,760 | 574,037 | May 25, 2023, 09:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | May 16, 2023 | Sale | $1.07 | 63,567 | 67,890 | 530,487 | May 18, 2023, 06:20 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | May 16, 2023 | Sale | $1.07 | 63,567 | 67,890 | 446,483 | May 18, 2023, 06:19 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Mar 01, 2023 | Sale | $0.88 | 91,868 | 80,614 | 1,622,481 | Mar 03, 2023, 08:01 AM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2023 | Sale | $0.88 | 13,034 | 11,437 | 295,231 | Mar 03, 2023, 08:01 AM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2023 | Sale | $0.88 | 14,123 | 12,393 | 601,564 | Mar 03, 2023, 08:01 AM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2023 | Sale | $0.88 | 20,412 | 17,912 | 281,869 | Mar 03, 2023, 08:01 AM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Mar 01, 2023 | Sale | $0.88 | 7,210 | 6,327 | 510,860 | Mar 03, 2023, 08:00 AM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Feb 27, 2023 | Sale | $0.81 | 38,632 | 31,416 | 1,660,740 | Mar 01, 2023, 04:07 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Feb 27, 2023 | Sale | $0.81 | 7,539 | 6,131 | 608,177 | Mar 01, 2023, 04:06 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Feb 27, 2023 | Sale | $0.81 | 7,539 | 6,131 | 517,260 | Mar 01, 2023, 04:05 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Aug 31, 2022 | Sale | $0.36 | 1,147 | 416 | 418,016 | Sep 01, 2022, 04:15 PM | |
| AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Director | Jun 03, 2022 | Sale | $0.36 | 4,567 | 1,653 | 43,430 | Jun 07, 2022, 04:03 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Feb 28, 2022 | Sale | $2.15 | 25,053 | 53,984 | 1,164,095 | Mar 02, 2022, 09:25 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Mar 01, 2022 | Sale | $2.17 | 53,973 | 117,159 | 1,432,409 | Mar 02, 2022, 09:25 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Feb 28, 2022 | Sale | $2.15 | 7,400 | 15,946 | 163,819 | Mar 02, 2022, 09:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2022 | Sale | $2.17 | 7,656 | 16,619 | 217,663 | Mar 02, 2022, 09:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Cotreau Violetta | SVP, Chief Accounting Officer | Feb 28, 2022 | Sale | $2.15 | 3,946 | 8,503 | 29,121 | Mar 02, 2022, 09:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2022 | Sale | $2.15 | 6,555 | 14,125 | 258,995 | Mar 02, 2022, 09:11 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2022 | Sale | $2.17 | 14,978 | 32,513 | 302,122 | Mar 02, 2022, 09:11 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Feb 28, 2022 | Sale | $2.15 | 6,479 | 13,961 | 130,546 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Mar 01, 2022 | Sale | $2.17 | 6,705 | 14,555 | 174,798 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Feb 28, 2022 | Sale | $2.15 | 6,555 | 14,125 | 265,748 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2022 | Sale | $2.17 | 14,507 | 31,490 | 308,875 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Mar 01, 2022 | Sale | $2.17 | 803 | 1,743 | 128,599 | Mar 02, 2022, 09:09 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Feb 28, 2022 | Sale | $2.15 | 7,400 | 15,946 | 69,402 | Mar 02, 2022, 09:09 PM | |
| AKBA | Akebia Therapeutics, Inc. | Cotreau Violetta | SVP, Chief Accounting Officer | Jan 03, 2022 | Sale | $2.29 | 5,833 | 13,335 | 33,067 | Jan 05, 2022, 04:11 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Aug 31, 2021 | Sale | $2.83 | 1,042 | 2,949 | 171,219 | Sep 02, 2021, 04:07 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Apr 01, 2021 | Sale | $3.40 | 952 | 3,237 | 137,025 | Apr 01, 2021, 08:35 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Apr 01, 2021 | Sale | $3.40 | 790 | 2,686 | 76,802 | Apr 01, 2021, 08:34 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Apr 01, 2021 | Sale | $3.40 | 1,060 | 3,604 | 272,303 | Apr 01, 2021, 08:33 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Apr 01, 2021 | Sale | $3.40 | 1,211 | 4,117 | 265,550 | Apr 01, 2021, 08:33 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Apr 01, 2021 | Sale | $3.40 | 4,109 | 13,971 | 1,152,153 | Apr 01, 2021, 08:32 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Apr 01, 2021 | Sale | $3.40 | 1,081 | 3,675 | 170,761 | Apr 01, 2021, 08:31 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Mar 01, 2021 | Sale | $3.40 | 49,990 | 169,771 | 1,141,416 | Mar 02, 2021, 04:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | CCO | Mar 01, 2021 | Sale | $3.40 | 6,749 | 22,920 | 128,825 | Mar 02, 2021, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2021 | Sale | $3.40 | 14,285 | 48,513 | 271,147 | Mar 02, 2021, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2021 | Sale | $3.40 | 14,547 | 49,403 | 263,058 | Mar 02, 2021, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2021 | Sale | $3.40 | 7,558 | 25,668 | 161,442 | Mar 02, 2021, 04:06 PM | |
| AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Director | Jun 08, 2020 | Sale | $12.10 | 4,567 | 55,261 | 37,833 | Jun 09, 2020, 04:17 PM | |
| AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Director | Jun 08, 2020 | Sale | $12.08 | 4,567 | 55,169 | 38,864 | Jun 09, 2020, 04:17 PM | |
| AKBA | Akebia Therapeutics, Inc. | GOWEN MAXINE | Director | Jun 08, 2020 | Sale | $12.05 | 4,567 | 55,032 | 24,133 | Jun 09, 2020, 04:17 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | CCO | Jun 01, 2020 | Sale | $11.58 | 6,426 | 74,413 | 73,574 | Jun 02, 2020, 04:34 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2020 | Sale | $8.70 | 6,972 | 60,656 | 204,960 | Mar 02, 2020, 07:29 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | Feb 28, 2020 | Sale | $8.70 | 7,050 | 61,335 | 212,756 | Mar 02, 2020, 07:28 PM | |
| AKBA | Akebia Therapeutics, Inc. | Amello Jason | SVP, CFO & Treasurer | Feb 28, 2020 | Sale | $8.70 | 6,976 | 60,691 | 144,642 | Mar 02, 2020, 07:27 PM | |
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Feb 28, 2020 | Sale | $8.70 | 3,454 | 30,050 | 84,679 | Mar 02, 2020, 07:26 PM | |
| AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Director | Nov 20, 2019 | Buy | $3.43 | 5,800 | 19,894 | 29,731 | Nov 22, 2019, 06:20 AM | |
| AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Director | Nov 20, 2019 | Buy | $3.52 | 15,000 | 52,800 | 28,700 | Nov 22, 2019, 06:20 AM | |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | Nov 20, 2019 | Buy | $3.58 | 27,000 | 96,660 | 37,000 | Nov 22, 2019, 06:19 AM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Nov 20, 2019 | Buy | $3.44 | 50,000 | 172,000 | 887,732 | Nov 21, 2019, 06:32 AM | |
| AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Director | Nov 20, 2019 | Buy | $3.41 | 50,000 | 170,500 | 63,700 | Nov 21, 2019, 06:31 AM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Jun 03, 2019 | Option Exercise | $0.47 | 287,000 | 134,890 | 836,232 | Jun 05, 2019, 04:05 PM | |
| AKBA | Akebia Therapeutics, Inc. | Jain Rita | SVP, Chief Medical Officer | Apr 11, 2019 | Option Exercise | $7.70 | 4,409 | 33,949 | 96,332 | Apr 12, 2019, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 11, 2019 | Option Exercise | $7.70 | 11,909 | 91,699 | 146,932 | Apr 12, 2019, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, CLO & Secretary | Apr 11, 2019 | Option Exercise | $7.70 | 11,929 | 91,853 | 154,806 | Apr 12, 2019, 04:00 PM | |
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Apr 11, 2019 | Option Exercise | $7.70 | 6,075 | 46,777 | 55,324 | Apr 12, 2019, 04:00 PM | |
| AKBA | Akebia Therapeutics, Inc. | Amello Jason | SVP, CFO & Treasurer | Apr 11, 2019 | Option Exercise | $7.70 | 13,148 | 101,240 | 118,618 | Apr 12, 2019, 04:00 PM | |
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Dec 12, 2018 | Option Exercise | $8.94 | 11,928 | 106,636 | 30,229 | Dec 13, 2018, 08:18 AM | |
| AKBA | Akebia Therapeutics, Inc. | Jain Rita | SVP, Chief Medical Officer | Dec 12, 2018 | Option Exercise | $8.94 | 8,659 | 77,411 | 20,741 | Dec 13, 2018, 08:17 AM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Dec 12, 2018 | Option Exercise | $8.94 | 20,175 | 180,364 | 101,284 | Dec 13, 2018, 08:15 AM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Dec 12, 2018 | Option Exercise | $8.94 | 23,385 | 209,062 | 93,841 | Dec 13, 2018, 08:14 AM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO & President | Dec 12, 2018 | Option Exercise | $8.94 | 135,697 | 1,213,131 | 374,617 | Dec 13, 2018, 08:10 AM | |
| AKBA | Akebia Therapeutics, Inc. | Amello Jason | SVP, CFO & Treasurer | Dec 12, 2018 | Option Exercise | $8.94 | 22,235 | 198,781 | 66,501 | Dec 13, 2018, 08:08 AM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Jul 11, 2018 | Option Exercise | $0.47 | 100,000 | 47,000 | 510,314 | Jul 12, 2018, 04:59 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Feb 15, 2018 | Sale | $14.62 | 1,000 | 14,620 | 21,499 | Feb 16, 2018, 04:07 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Oct 02, 2017 | Sale | $19.64 | 1,188 | 23,332 | 22,499 | Oct 04, 2017, 04:21 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Oct 02, 2017 | Sale | $19.89 | 7,803 | 155,188 | 108,054 | Oct 04, 2017, 04:21 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Oct 02, 2017 | Sale | $19.64 | 1,398 | 27,457 | 95,826 | Oct 04, 2017, 04:20 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Sep 28, 2017 | Sale | $19.30 | 5,000 | 96,500 | 97,224 | Oct 02, 2017, 04:04 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Aug 15, 2017 | Sale | $15.00 | 5,000 | 75,000 | 102,224 | Aug 17, 2017, 04:06 PM | |
| AKBA | Akebia Therapeutics, Inc. | Satter Muneer A | Director | Jul 05, 2017 | Buy | $14.50 | 1,034,482 | 14,999,989 | 3,037,042 | Jul 11, 2017, 04:14 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jul 03, 2017 | Sale | $14.26 | 1,399 | 19,947 | 107,224 | Jul 06, 2017, 12:25 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Jul 03, 2017 | Sale | $14.26 | 1,554 | 22,156 | 109,607 | Jul 06, 2017, 12:24 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Jul 03, 2017 | Sale | $14.27 | 990 | 14,127 | 23,687 | Jul 06, 2017, 12:23 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 03, 2017 | Sale | $9.18 | 1,401 | 12,858 | 108,623 | Apr 04, 2017, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Apr 03, 2017 | Sale | $9.20 | 991 | 9,119 | 24,677 | Apr 04, 2017, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 03, 2017 | Sale | $9.18 | 1,556 | 14,280 | 109,856 | Apr 04, 2017, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | Jan 19, 2017 | Option Exercise | $0.47 | 20,000 | 9,400 | 373,480 | Jan 23, 2017, 04:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jan 01, 2017 | Sale | $10.49 | 1,629 | 17,089 | 70,524 | Jan 03, 2017, 04:02 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Jan 03, 2017 | Sale | $10.46 | 1,980 | 20,711 | 25,668 | Jan 03, 2017, 04:02 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Jan 01, 2017 | Sale | $10.49 | 1,810 | 18,988 | 82,912 | Jan 03, 2017, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Oct 03, 2016 | Sale | $8.96 | 1,981 | 17,746 | 27,648 | Oct 04, 2016, 04:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Oct 01, 2016 | Sale | $8.95 | 1,401 | 12,546 | 72,153 | Oct 04, 2016, 04:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Oct 01, 2016 | Sale | $8.95 | 1,556 | 13,934 | 83,915 | Oct 04, 2016, 04:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Nash Duane | Director | Jul 06, 2016 | Sale | $7.48 | 1,980 | 14,819 | 29,629 | Jul 07, 2016, 04:07 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jul 05, 2016 | Sale | $7.47 | 1,402 | 10,468 | 73,554 | Jul 06, 2016, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Jul 05, 2016 | Sale | $7.47 | 1,557 | 11,625 | 85,471 | Jul 06, 2016, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 04, 2016 | Sale | $9.41 | 1,556 | 14,642 | 85,528 | Apr 05, 2016, 04:03 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 04, 2016 | Sale | $9.41 | 1,401 | 13,183 | 74,956 | Apr 05, 2016, 04:01 PM |
Menu